Objective: To evaluate the safety and efficacy of combining deferiprone(DFP)and deferoxamine(DFO)in iron chelation therapy in patients with thalassemia.
探讨去铁酮(DFP)和去铁胺(DFO)联用药对重症地中海贫血螯治疗的安全性和有效性。
Objective: To evaluate the safety and efficacy of combining deferiprone(DFP)and deferoxamine(DFO)in iron chelation therapy in patients with thalassemia.
探讨去铁酮(DFP)和去铁胺(DFO)联用药对重症地中海贫血螯治疗的安全性和有效性。
声明:以、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。